<DOC>
	<DOCNO>NCT02256488</DOCNO>
	<brief_summary>The purpose study evaluate immunologic equivalence three consecutive lot cell base trivalent subunit influenza vaccine ( TIVc ) , assess immunogenicity , safety tolerability vaccine egg base trivalent subunit influenza vaccine ( TIVf ) . The study comprise 1 vaccination , 2 clinic visit , 3 reminder call 2 blood draw . Female subject childbearing potential tested pregnancy administration vaccine include use agree continue use contraception course study . The total study participation time per subject 3 week .</brief_summary>
	<brief_title>Safety Immunogenicity Two Trivalent Subunit Influenza Vaccines Healthy Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Males females 18 49 year age . Subjects provide informed consent . Individuals good health Chronic acute illness would interfere subject 's safety and/or could interfere evaluation study vaccine , include know history anaphylaxis , serious vaccine reaction hypersensitivity , know immunodeficiency receive immunosuppressive therapy . Female childbearing potential use acceptable contraceptive method , pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>